COMMUNIQUÉS West-GlobeNewswire

Publishing of Orion Corporation's Half Year Report for January-June 2019 on 17 July 2019
27/06/2019
ORION CORPORATION PRESS RELEASE 27 JUNE 2019 at 14.30 EEST Publishing of Orion Corporation's Half Year Report for January-June 2019 on 17 July 2019 Orion will publish its Half Year Report for January-June 2019 on [...]
ProMIS Neurosciences’ PMN310 Shows Greater Therapeutic Potential vs. Other Amyloid-Beta-Directed Antibodies
27/06/2019
Data presented at Keystone Symposium on Neurodegenerative Diseases TORONTO, Ontario and CAMBRIDGE, Mass., June 27, 2019 (GLOBE NEWSWIRE) -- ProMIS Neurosciences, Inc. (TSX: PMN) (OTCQB: ARFXF), a biotechnology company [...]
OpGen’s Acuitas® AMR Gene Panel Shows Potential for Reducing Total Time to Targeted Therapy
27/06/2019
Collaborator data demonstrating OpGen’s rapid prediction of antibiotic resistance and detection of uropathogens presented at ASM Microbe 2019 GAITHERSBURG, Md., June 27, 2019 (GLOBE NEWSWIRE) -- OpGen, Inc . (Nasdaq: [...]
Prolaris® Test Accurately Predicts Risk of Metastasis in Men Diagnosed with Localized Prostate Cancer
27/06/2019
Validation Study Shows Prolaris Test Identifies Men Who May Benefit from Surgery or Radiation at the Time of a Prostate Cancer Diagnosis SALT LAKE CITY, June 27, 2019 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: [...]
XBiotech remporte le « Prix de l'immobilier commercial pour le développement industriel » pour son siège social situé à Austin, au Texas
27/06/2019
AUSTIN, Texas, 27 juin 2019 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ: XBIT) a annoncé aujourd'hui être le récipiendaire du premier prix 2019 de l'immobilier commercial pour le développement industriel, choisi par l' [...]
Assembly Biosciences Announces First Patient Dosed with ABI-M201 in Phase 1b Clinical Trial for Mildly to Moderately Active Ulcerative Colitis
27/06/2019
First oral microbiome biologic drug candidate from Assembly’s novel microbiome platform to enter clinical trials in patients ABI-M201 utilizes Assembly’s proprietary and patented Gemicel ® capsule-in-capsule delivery [...]
Antares Pharma Announces Amendment to Existing Loan and Security Agreement With Hercules Capital
27/06/2019
Amendment Increases Loan By Up To $25 Million in Non-Dilutive Debt Financing EWING, N.J., June 27, 2019 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) (“Antares” or “the Company”) today announced that it has [...]
HealthEquity to Acquire WageWorks Accelerating Market-Wide Transition to HSAs
27/06/2019
Delivers sustained growth, significant synergies, rapid deleveraging DRAPER, Utah and SAN MATEO, Calif., June 27, 2019 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY) ("HealthEquity"), the nation's largest [...]
Novavax Confirms Accelerated Approval Pathway Available for Licensure of NanoFlu™
27/06/2019
Pivotal Phase 3 clinical trial expected to initiate in the fall of 2019 Top-line clinical data expected in the first quarter of 2020 GAITHERSBURG, Md., June 27, 2019 (GLOBE NEWSWIRE) -- Novavax, Inc. (NASDAQ: NVAX), a [...]
NeuroMetrix Provides Strategic Update
27/06/2019
WALTHAM, Mass., June 27, 2019 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO), a health technology company addressing chronic health conditions including chronic pain, sleep disorders and diabetes, today reported on [...]
Trevena Appoints Barry Shin as Chief Financial Officer
27/06/2019
CHESTERBROOK, Pa., June 27, 2019 (GLOBE NEWSWIRE) -- Trevena, Inc. (Nasdaq: TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with Central Nervous System [...]
AgraFlora Organics Provides Licensing Guidance and Operational Updates at GMP-Certified GTA Bottling Facility
27/06/2019
VANCOUVER, British Columbia, June 27, 2019 (GLOBE NEWSWIRE) -- AgraFlora Organics International Inc. (“ AgraFlora ” or the “ Company ”) ( CSE: AGRA) (Frankfurt: PU31) (OTCPK: PUFXF ), a growth oriented and diversified [...]
NEOVACS ANNOUNCES THE APPOINTMENT of Dr. VIRGINIA PASCUAL AS MEDICAL AND SCIENTIFIC ADVISOR
27/06/2019
PRESS RELEASE · PRESS RELEASE · PRESS RELEASE NEOVACS ANNOUNCES THE APPOINTMENT of Dr. VIRGINIA PASCUAL AS MEDICAL AND SCIENTIFIC ADVISOR Paris and Boston, June 27 th , 2019 – Neovacs – 7:30 am CEST - (Euronext Growth [...]
NÉOVACS ANNONCE LA NOMINATION DU Dr. VIRGINIA PASCUAL EN TANT QUE CONSEILLÈRE MÉDICALE ET SCIENTIFIQUE
27/06/2019
COMMUNIQUÉ DE PRESSE · COMMUNIQUÉ DE PRESSE · COMMUNIQUÉ DE PRESSE NÉOVACS ANNONCE LA NOMINATION DU Dr. VIRGINIA PASCUAL EN TANT QUE CONSEILLÈRE MÉDICALE ET SCIENTIFIQUE Paris et Boston, le 27 juin 2019 - 07h30 CEST - [...]
Sanofi : FDA to review MenQuadfi, a meningococcal vaccine candidate
27/06/2019
FDA to review MenQuadfi TM 1 , a meningococcal vaccine candidate PARIS – June 27, 2019 - The U.S. Food and Drug Administration (FDA) has accepted for review the Biologics License Application (BLA) for Sanofi’s MenQuadfi [...]
Sanofi : La FDA va examiner le dossier du candidat-vaccin méningococcique MenQuadfi
27/06/2019
La FDA va examiner le dossier du candidat-vaccin méningococcique MenQuadfi TM 1 PARIS – Le 27 juin 2019 - La Food and Drug Administration (FDA) des États-Unis a accepté d’examiner la demande de licence de produit [...]
Bone Therapeutics SA to raise capital through private placement of new shares and issuance of non-dilutive subordinated bonds
27/06/2019
NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH IT WOULD BE UNLAWFUL TO [...]
Bone Therapeutics SA annonce le lancement d’un placement privé et l’émission d’obligations subordonnées non dilutives
27/06/2019
LE PRÉSENT COMMUNIQUÉ NE DOIT PAS ÊTRE PUBLIÉ, DISTRIBUÉ OU DIFFUSÉ, TOTALEMENT OU PARTIELLEMENT, DIRECTEMENT OU INDIRECTEMENT, AUX ÉTATS-UNIS, EN AUSTRALIE, AU CANADA, AU JAPON, EN AFRIQUE DU SUD, OU DANS TOUT AUTRE [...]
Atlas Nanotech of Guadalajara to begin alliance with European Nano Medical S.R.O.
27/06/2019
GUADALAJARA, Mexico, June 27, 2019 (GLOBE NEWSWIRE) -- via NetworkWire – CSSI (Costas Inc.) DBA Atlas Nanotech has entered an accord with Nano Medical S.R.O. of the Czech Republic. The first objective of the accord aims [...]

Pages